Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ziupa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Cardiovascular Medicine|August 1, 2022
Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT SyndromeMarina Rieder, Paul Kreifels, Judith Stuplich, et al.
Plos One|September 23, 2014
Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbitsDavid Ziupa, Julia Beck, Gerlind Franke, et al.
International Journal of Cardiology. Heart & Vasculature|April 8, 2022
Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTSPaul Kreifels, Ilona Bodi, Tibor Hornyik, et al.
International Journal of Cardiology|July 19, 2018
Electro-mechanical (dys-)function in long QT syndrome type 1David Ziupa, Marius Menza, Susanne Koppermann, et al.
Heart Rhythm|July 30, 2013
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbitsKatja E Odening, Bernd A Jung, Corinna N Lang, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Cardiovascular Medicine|August 1, 2022
Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT SyndromeMarina Rieder, Paul Kreifels, Judith Stuplich, et al.
Plos One|September 23, 2014
Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbitsDavid Ziupa, Julia Beck, Gerlind Franke, et al.
International Journal of Cardiology. Heart & Vasculature|April 8, 2022
Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTSPaul Kreifels, Ilona Bodi, Tibor Hornyik, et al.
International Journal of Cardiology|July 19, 2018
Electro-mechanical (dys-)function in long QT syndrome type 1David Ziupa, Marius Menza, Susanne Koppermann, et al.
Heart Rhythm|July 30, 2013
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbitsKatja E Odening, Bernd A Jung, Corinna N Lang, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
Pageof 1